CDC to revisit AZT, post-exposure guidelines. Centers for Disease Control and Prevention.
D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D017848:Blood-Borne Pathogens; D002487:Centers for Disease Control and Prevention, U.S.; D017408:Guidelines as Topic; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006282:Health Personnel; D006801:Humans; D008251:Macaca; D016602:Needlestick Injuries; D016273:Occupational Exposure; D063065:Organophosphonates; D015215:Zidovudine / Q000627:therapeutic use*
D000998:Antiviral Agents; D063065:Organophosphonates; D015215:Zidovudine; C053001:adefovir; D000225:Adenine